The E6(R3) update, finalized on January 6 2025 (Step 4 of the ICH process), is the most significant overhaul since the 2016 E6(R2) revision. It reflects advancements in clinical trial methods, technology, and regulatory expectations over nearly a decade. Why it matters: Real-World Applications Latest Research or Updates The E6(R3) final document consists of: Key…

The pharmaceutical industry stands at a transformative crossroads. After decades of escalating costs, extended timelines, and disappointing success rates, a technological revolution is reshaping how we discover, develop, and deliver life-saving medications. Artificial intelligence in drug development has evolved from an experimental concept to an operational necessity that’s driving the industry’s most significant breakthroughs. Consider…